Update date
31 Dec 2024
Shareable Research Card
This metric view shows TC BioPharm (Holdings) plc amortization of intangible assets history from SEC company facts.
Use it to verify the latest reported value, compare nearby periods, and jump to a cross-company ranking when a curated insight exists.
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Values may differ by reporting period and company taxonomy.
Return Loop
This metric history becomes more useful after the next quarterly or annual filing because the latest reported value, period, and company comparison context can all change.
Metric freshness comes from the latest SEC company fact available for this taxonomy tag and the paired company facts page.
Latest update
Latest reported amortization of intangible assets: £50,682. Open the source-backed page to compare this metric with the newest filing-backed context.
Update date
31 Dec 2024
Page type
Metric history
Latest period
2024
SEC-backed company facts were refreshed from filings filed on 09 May 2025.
Benchmark Context
TC BioPharm (Holdings) plc sits in the bottom quarter of the current amortization of intangible assets sample.
Compared with
Compared with 2 companies reporting amortization of intangible assets in GBP. This keeps the comparison on the same metric and unit family.
Why this is notable
This is about 0x the current sample midpoint. Amortization of Intangible Assets is up about 40% versus the comparable prior period.
Peer comparisons use the same metric and compatible units only. Latest reported periods may differ across companies, so open each company page before drawing conclusions.
Save this filer page
Create a free account to keep this page in your watchlists. After verification, we will save it automatically and open your saved research list.
Financial Metric Page
Latest period: 2024. Period end: 31 Dec 2024. Units: GBP. Frequency: annual and quarterly.
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Source: SEC company facts
Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Reporting periods may differ by company.
Compare latest available Amortization of Intangible Assets levels across SEC-reporting companies, then open each company metric page for SEC-backed verification. Reporting periods may differ by company.
TC BioPharm (Holdings) plc appears at rank #2 in the latest comparison sample.
| Rank | Company | Latest value | Report period | Next step |
|---|---|---|---|---|
| 1 | WeShop Holdings Ltd (wshp) | £2,000,000 | Year - 31 Dec 2025 | Open WeShop Holdings Ltd Amortization of Intangible Assets |
| 2 | TC BioPharm (Holdings) plc | £50,682 | Year - 31 Dec 2024 | Open TC BioPharm (Holdings) plc Amortization of Intangible Assets |
Compare periods with the same frequency first, then use YoY and TTM series to confirm whether changes are structural or one-off.
| Period | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|
| 2024 | £50,682 | +£14,400 | +40% | 01 Jan 2024 | 31 Dec 2024 | 20-F | 09 May 2025 | 2024 | FY |
| 2023 | £36,282 | -£18,764 | -34% | 01 Jan 2023 | 31 Dec 2023 | 20-F | 09 May 2025 | 2024 | FY |
| 2022 | £55,046 | 01 Jan 2022 | 31 Dec 2022 | 20-F | 09 May 2025 | 2024 | FY |
| Period | TTM Value | Value | YoY Chg | Change % | Start Date | End Date | Report | Filed | Fiscal Year | Fiscal Period |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 2024 | £12,276 | +£461 | +3.9% | 01 Jan 2024 | 31 Mar 2024 | 10-Q | 15 May 2024 | 2024 | Q1 | |
| Q1 2023 | £11,815 | 01 Jan 2023 | 31 Mar 2023 | 10-Q | 15 May 2024 | 2024 | Q1 |